View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
October 29, 2015

Belgian firm Lucimed introduces new Luminette light therapy device

Belgium-based Lucimed has launched a new light therapy device, Luminette, a portable solution for people suffering from seasonally induced issues.

Luci

Belgium-based Lucimed has launched a new light therapy device, Luminette, a portable solution for people suffering from seasonally induced issues.

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

Currently available in Europe, the new light therapy glasses provide relief from seasonal affective disorder (SAD), sleep disorders and circadian rhythm issues such as jet lag and shift work.

Luminette was developed after four years of university research and clinical trials.

Compared to traditional light therapy devices, which require users to remain stationary in front of a lightbox, the new device is worn like a pair of glasses that sit just above the eyes.

The company noted that around 20 minutes of Luminette will help to treat and prevent issues during months when sunlight is reduced.

The 1,500-lux blue-enriched white light of Luminette is output from LEDs, which reaches the diffraction lens and stimulates the retina, without affecting vision.

The company noted that light shines downwards into the eyes, just as sunlight naturally does and receptors in the eye then send a signal to the body’s circadian clock regulator, stopping the secretion of melatonin, which naturally wakes up all body systems.

"We live in an active society and Luminette is designed to provide relief for people and their on-the-go lives"

Lucimed managing director Eric Delloye said: "We’re thrilled to be bringing Luminette to the world and helping people that face health issues during the fall and winter months.

"We live in an active society and Luminette is designed to provide relief for people and their on-the-go lives."

The company has also introduced Luminette app, which generates biological clock rephasing programmes based on algorithms developed by the chronotherapist Roland Pec.

The programmes include all known chronobiological tools such as light exposure, avoidance of light, taking melatonin, sleep and others.


Image: Lucimed light therapy glasses, Luminette. Photo: courtesy of PRNewsFoto / Lucimed.

Related Companies

Free Report
img

Medical Device Industry Landscape In Asia-Pacific

GlobalData's APAC Medical Devices Industry Landscape – 2022 free study breaks down the APAC medical devices market by segment and region and includes insights on local and global competitors, pipeline product developments, clinical trials studies, and significant deals in the industry. The APAC medical device industry witnessed significant developments, launches, implementations, and adoption of new medical device technologies in the past decade, however the high cost of devices, regulatory hurdles, reimbursement pressure, and healthcare budget constraints have challenged market expansion across various territories and segments. APAC is the fastest growing regional market for medical device clinical trials, with China and Japan emerging as major clinical trial hotspots. The growth in medical device clinical trials in the APAC region is attributed to an increase in research partnerships between biopharma companies and clinical research organizations (CROs). This report also provides an in-depth analysis of the medical device market's opportunities and challenges, the influence of COVID-19 on the market, and government activities aimed to develop the APAC medical device market.
by GlobalData
Enter your details here to receive your free Report.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network